Gene Expression from Recombinant Viral Vectors in the Central Nervous System after Blood-Brain Barrier Disruption
- 1 May 1995
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 36 (5), 965-970
- https://doi.org/10.1227/00006123-199505000-00012
Abstract
DIRECT INTRACEREBRAL INJECTION of recombinant adenoviral vectors within the brain parenchyma or the ventricular system results in a limited volume ofKeywords
This publication has 18 references indexed in Scilit:
- Expression of Escherichia coli β-Galactosidase and Rat HPRT in the CNS of Macaca mulatta Following Adenoviral Mediated Gene TransferExperimental Neurology, 1994
- Long-term correction of rat model of Parkinson's disease by gene therapyNature, 1993
- Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectorsNature Genetics, 1993
- Transfer of a foreign gene into the brain using adenovirus vectorsNature Genetics, 1993
- A model system for in vivo gene transfer into the central nervous system using an adenoviral vectorNature Genetics, 1993
- Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.Journal of Clinical Oncology, 1991
- CORRECTION OF LYSOSOMAL ENZYME DEFICIENCY IN VARIOUS ORGANS OF β-GLUCURONIDASE-DEFICIENT MICE BY ALLOGENEIC BONE MARROW TRANSPLANTATIONTransplantation, 1987
- Therapeutic Efficacy of Multiagent Chemotherapy with Drug Delivery Enhancement by Blood-Brain Barrier Modification in GlioblastomaNeurosurgery, 1986
- Hyperosmotic arabinose solutions open the tight junctions between brain capillary endothelial cells in tissue cultureBrain Research, 1984
- The blood-brain barrier to proteins under normal and pathological conditionsJournal of the Neurological Sciences, 1970